Direct contact between tumor cells and platelets initiates a FAK-dependent F3/TGF-β positive feedback loop that promotes tumor progression and EMT in osteosarcoma
- PMID: 38641310
- DOI: 10.1016/j.canlet.2024.216902
Direct contact between tumor cells and platelets initiates a FAK-dependent F3/TGF-β positive feedback loop that promotes tumor progression and EMT in osteosarcoma
Abstract
Platelets have received growing attention for their roles in hematogenous tumor metastasis. However, the tumor-platelet interaction in osteosarcoma (OS) remains poorly understood. Here, using platelet-specific focal adhesion kinase (FAK)-deficient mice, we uncover a FAK-dependent F3/TGF-β positive feedback loop in OS. Disruption of the feedback loop by inhibition of F3, TGF-β, or FAK significantly suppresses OS progression. We demonstrate that OS F3 initiated the feedback loop by increasing platelet TGF-β secretion, and platelet-derived TGF-β promoted OS F3 expression in turn and modulated OS EMT process. Immunofluorescence results indicate platelet infiltration in OS niche and we verified it was mediated by platelet FAK. In addition, platelet FAK was proved to mediate platelet adhesion to OS cells, which was vital for the initiation of F3/TGF-β feedback loop. Collectively, these findings provide a rationale for novel therapeutic strategies targeting tumor-platelet interplay in metastatic OS.
Keywords: Anti-Platelet treatment; F3; FAK; Osteosarcoma; TGF-β; Tumor-platelet interactions.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing interest The authors declare no potential conflicts of interest.
Similar articles
-
PDGFRB promotes dedifferentiation and pulmonary metastasis through rearrangement of cytoskeleton under hypoxic microenvironment in osteosarcoma.Cell Signal. 2025 Jan;125:111501. doi: 10.1016/j.cellsig.2024.111501. Epub 2024 Nov 4. Cell Signal. 2025. PMID: 39505287
-
Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells.Cell Death Dis. 2014 May 15;5(5):e1224. doi: 10.1038/cddis.2014.189. Cell Death Dis. 2014. PMID: 24832596 Free PMC article.
-
Platelet-Derived TGF-β Induces Tissue Factor Expression via the Smad3 Pathway in Osteosarcoma Cells.J Bone Miner Res. 2018 Nov;33(11):2048-2058. doi: 10.1002/jbmr.3537. Epub 2018 Jul 20. J Bone Miner Res. 2018. PMID: 29949655
-
Feedback modulation of endothelial cells promotes epithelial-mesenchymal transition and metastasis of osteosarcoma cells by Von Willebrand Factor release.J Cell Biochem. 2019 Sep;120(9):15971-15979. doi: 10.1002/jcb.28875. Epub 2019 May 17. J Cell Biochem. 2019. PMID: 31099074
-
Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.Breast Cancer Res. 2009;11(5):R68. doi: 10.1186/bcr2360. Breast Cancer Res. 2009. PMID: 19740433 Free PMC article.
Cited by
-
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy.Biomark Res. 2025 Feb 11;13(1):27. doi: 10.1186/s40364-025-00742-w. Biomark Res. 2025. PMID: 39934930 Free PMC article. Review.
-
Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1-NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity.Adv Sci (Weinh). 2025 Aug;12(29):e15276. doi: 10.1002/advs.202415276. Epub 2025 May 19. Adv Sci (Weinh). 2025. PMID: 40387572 Free PMC article.
-
WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.J Exp Clin Cancer Res. 2025 Jul 11;44(1):201. doi: 10.1186/s13046-025-03456-x. J Exp Clin Cancer Res. 2025. PMID: 40646517 Free PMC article.
-
Treatment of Distal Femoral Malignant Mesenchymal Tumor With Extensor Mechanism Transfer: A Case Report and Surgical Technique.Cureus. 2024 Dec 7;16(12):e75303. doi: 10.7759/cureus.75303. eCollection 2024 Dec. Cureus. 2024. PMID: 39781131 Free PMC article.
-
Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities.Exp Hematol Oncol. 2025 Jun 13;14(1):83. doi: 10.1186/s40164-025-00676-x. Exp Hematol Oncol. 2025. PMID: 40514754 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous